Druglike, a Web3 drug discovery software platform co-founded by Martin Shkreli, is releasing a demo, website, and whitepaper detailing its efforts to democratize the costs, access, and rewards of computational drug discovery.
Druglike, a Web3 drug discovery software platform co-founded by Martin Shkreli, is releasing a demo, website, and whitepaper detailing its efforts to democratize the costs, access, and rewards of computational drug discovery.